Literature DB >> 2819825

DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators.

Y Pommier, J M Covey, D Kerrigan, J Markovits, R Pham.   

Abstract

The DNA unwinding effects of some 9-aminoacridine derivatives were compared under reaction conditions that could be used to study drug-induced topoisomerase II inhibition. An assay was designed to determine drug-induced DNA unwinding by using L1210 topoisomerase I. 9-aminoacridines could be ranked by decreasing unwinding potency: compound C greater than or equal to 9-aminoacridine greater than o-AMSA greater than or equal to compound A greater than compound B greater than m-AMSA. Ethidium bromide was more potent than any of the 9-aminoacridines. This assay is a fast and simple method to compare DNA unwinding effects of intercalators. It led to the definition of a drug intrinsic unwinding constant (k). An additional finding was that all 9-aminoacridines and ethidium bromide inhibited L1210 topoisomerase I. Enzyme inhibition was detectable at low enzyme concentrations (less than or equal to 1 unit) and when the kinetics of topoisomerase I-mediated DNA relaxation was studied. Topoisomerase I inhibition was not associated with DNA swivelling or cleavage.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819825      PMCID: PMC306134          DOI: 10.1093/nar/15.16.6713

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.

Authors:  T C Rowe; G L Chen; Y H Hsiang; L F Liu
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

2.  Potential antitumor agents. 14. Acridylmethanesulfonanilides.

Authors:  B F Cain; R N Seelye; G J Atwell
Journal:  J Med Chem       Date:  1974-09       Impact factor: 7.446

3.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

4.  The degree of unwinding of the DNA helix by ethidium. I. Titration of twisted PM2 DNA molecules in alkaline cesium chloride density gradients.

Authors:  J C Wang
Journal:  J Mol Biol       Date:  1974-11-15       Impact factor: 5.469

5.  Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation.

Authors:  M Waring
Journal:  J Mol Biol       Date:  1970-12-14       Impact factor: 5.469

6.  Potential antitumour agents. 11. 9-anilinoacridines.

Authors:  B F Cain; G J Atwell; R N Seelye
Journal:  J Med Chem       Date:  1971-04       Impact factor: 7.446

7.  Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.

Authors:  Y Pommier; J K Minford; R E Schwartz; L A Zwelling; K W Kohn
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

8.  Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II.

Authors:  J Minford; Y Pommier; J Filipski; K W Kohn; D Kerrigan; M Mattern; S Michaels; R Schwartz; L A Zwelling
Journal:  Biochemistry       Date:  1986-01-14       Impact factor: 3.162

9.  Potential antitumor agents. 16.4'-(Acridin-9-ylamino)methanesulfonanilides.

Authors:  B F Cain; G J Atwell; W A Denny
Journal:  J Med Chem       Date:  1975-11       Impact factor: 7.446

10.  The experimental antitumour properties of three congeners of the acridylmethanesulphonanilide (AMSA) series.

Authors:  B F Cain; G J Atwell
Journal:  Eur J Cancer       Date:  1974-08       Impact factor: 9.162

View more
  24 in total

1.  Molecular and cellular pharmacology of the novel noncamptothecin topoisomerase I inhibitor Genz-644282.

Authors:  Dhriti Sooryakumar; Thomas S Dexheimer; Beverly A Teicher; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2011-06-02       Impact factor: 6.261

2.  A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.

Authors:  Ning Wu; Xi-Wei Wu; Keli Agama; Yves Pommier; Jun Du; Ding Li; Lian-Quan Gu; Zhi-Shu Huang; Lin-Kun An
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

3.  Fluorescence and circular dichroism studies on binding and conformational aspects of an anti-leukemic drug with DNA.

Authors:  Ashwini H Hegde; J Seetharamappa
Journal:  Mol Biol Rep       Date:  2013-11-06       Impact factor: 2.316

4.  7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents.

Authors:  Evgeny Kiselev; Sean DeGuire; Andrew Morrell; Keli Agama; Thomas S Dexheimer; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2011-08-08       Impact factor: 7.446

5.  Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage.

Authors:  Amanda C Gentry; Steven L Pitts; Michael J Jablonsky; Christian Bailly; David E Graves; Neil Osheroff
Journal:  Biochemistry       Date:  2011-03-28       Impact factor: 3.162

Review 6.  Topoisomerases, new targets in cancer chemotherapy.

Authors:  J G Zijlstra; S de Jong; E G de Vries; N H Mulder
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

7.  Thermodynamics of the interactions of m-AMSA and o-AMSA with nucleic acids: influence of ionic strength and DNA base composition.

Authors:  R M Wadkins; D E Graves
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

8.  Uncharacterized Bacterial Structures Revealed by Electron Cryotomography.

Authors:  Megan J Dobro; Catherine M Oikonomou; Aidan Piper; John Cohen; Kylie Guo; Taylor Jensen; Jahan Tadayon; Joseph Donermeyer; Yeram Park; Benjamin A Solis; Andreas Kjær; Andrew I Jewett; Alasdair W McDowall; Songye Chen; Yi-Wei Chang; Jian Shi; Poorna Subramanian; Cristina V Iancu; Zhuo Li; Ariane Briegel; Elitza I Tocheva; Martin Pilhofer; Grant J Jensen
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

9.  Synthesis and biological evaluation of 6-substituted indolizinoquinolinediones as catalytic DNA topoisomerase I inhibitors.

Authors:  Le-Mao Yu; Xiao-Ru Zhang; Xiao-Bing Li; Yuan Yang; Hong-Yu Wei; Xi-Xin He; Lian-Quan Gu; Zhi-Shu Huang; Yves Pommier; Lin-Kun An
Journal:  Eur J Med Chem       Date:  2015-07-08       Impact factor: 6.514

10.  Inhibitors of human immunodeficiency virus integrase.

Authors:  M R Fesen; K W Kohn; F Leteurtre; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.